INAH Luzern GmbH

The company aims to operate a medical institute for psychiatry, psychotherapy, and neurology with a focus on neurotechnological, interventional therapy methods (particularly deep transcranial magnetic stimulation, dTMS, and repetitive transcranial magnetic stimulation, rTMS), as well as the creation of insurance medical expert opinions and reports (particularly for social, daily allowance, and private insurances). The company provides medical services in diagnostics and treatment in the area of compulsory health insurance (OKP/KVG) and supplementary insurances (VVG), particularly in neuro-psychiatry, preventive medicine (executive health), cognitive restitution, and evidence-based neuro-enhancement. It also aims to create medical certificates, as well as the development, trade, and dispensing of medicines, dietary supplements, and medical devices. The company can conduct medical training and further education (recognized by SIWF) and provide consulting services. The company can participate in other businesses, acquire or establish similar or related businesses, set up branches and subsidiaries, and enter into any transactions and conclude contracts that are directly or indirectly related to the purpose of the company. The company can acquire, dispose of, encumber, manage, lease, and develop real estate. The company can also provide financing for its own or third-party account, including the financing of medical equipment (leasing), as well as guarantees and bonds for subsidiaries and third parties. The company can also acquire, register, manage, encumber, and dispose of patents, licenses, and all types of intellectual property rights.